News & Updates

Empagliflozin provides a significant clinical benefit within 90 days and shows no safety concerns in patients hospitalized for acute heart failure (HF), according to results of the EMPULSE trial reported at the American Heart Association (AHA) Scientific Sessions 2021.

Electronic nicotine delivery devices (ENDS) or e-cigarettes appear to be detrimental to men, with a recent study suggesting that its use contributes to a heightened risk of erectile dysfunction.

Weight gain in between pregnancies worsens the risk hypertensive disorders of pregnancy (HDP), a recent study has found.

Ninety-day supplementation of iron and folic acid (IFA) with or without vitamin B12 results in a reduction in iron and vitamin B12 deficiency and a decrease in the overall proportion of anaemia, reveals a study in India. However, adding vitamin B12 to IFA supplementation does not contribute to the improvement of haemoglobin levels among adolescent girls.

Cisplatin-based adjuvant chemotherapy confers substantial survival benefit in patients with muscle-invasive bladder cancer, reports a recent meta-analysis of randomized controlled trials (RCT).